{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.14127"}, {"@name": "filename", "#text": "20394_02%20-%20conclusao_referencias%20bibliograficas.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "81\n\n5. CONCLUS\u00c3O \n\nAs estirpes de Bifidobacterium breve (UFVCC 1083, UFVCC 1091, \n\nUFVCC 1099, UFVCC 1103, UFVCC 1105, UFVCC 1108 e UFVCC 1111) de \n\norigem humana, utilizadas na presente experimenta\u00e7\u00e3o, n\u00e3o promoveram \n\nefeitos adversos na sa\u00fade geral dos animais testados, uma vez que n\u00e3o \n\ninduziram toxicidade oral cr\u00f4nica (n\u00e3o promovendo crescimento anormal do \n\nf\u00edgado, rins, cora\u00e7\u00e3o e ba\u00e7o dos animais estudados) e nem promoveram \n\ntransloca\u00e7\u00e3o de bacterias do trato gastrointestinal para outros \u00f3rg\u00e3os ap\u00f3s \n\n21 dias de tratamento. No entanto, recomenda-se a realiza\u00e7\u00e3o da mesma \n\nexperimenta\u00e7\u00e3o com outros mam\u00edferos, incluindo humanos sadios, antes da \n\nimplanta\u00e7\u00e3o dessas estirpes nos bancos de leite humano. Recomenda-se \n\ntamb\u00e9m, verificar a toxicidade oral aguda, ministrando concentra\u00e7\u00f5es mais \n\nelevadas do pool probi\u00f3tico por um menor tempo.  \n\n\n\n 82\n\nCONCLUS\u00c3O GERAL \n\nAs 31 estirpes de Bifidobacterium breve isoladas de rec\u00e9m-nascidos \n\napresentaram susceptibilidade vari\u00e1vel aos 14 antibi\u00f3ticos avaliados, \n\nsugerindo que este fen\u00f3tipo \u00e9 estirpe dependente. No entanto, observou-se \n\nque a maioria das estirpes foram sens\u00edveis aos antimicrobianos, o que \u00e9 \n\numa caracter\u00edstica de seguran\u00e7a importante no processo de sele\u00e7\u00e3o desses \n\nisolados para uso como probi\u00f3tico em bancos de leite humano, devido a \n\npossibilidade de transfer\u00eancia do genes de resist\u00eancia no ambiente \n\nintestinal.  \n\nOs isolados de Bifidobacterium breve avaliados nesta experimenta\u00e7\u00e3o \n\napresentaram uma variabilidade na sua a\u00e7\u00e3o antagonista sobre Clostridium \n\ndifficile, Staphylococcus aureus, Escherichia coli, Salmonella typhimurium e \n\nListeria monocytogenes pelo m\u00e9todo \u201cspot\u201d. Verificou-se tamb\u00e9m que essa \n\ninibi\u00e7\u00e3o foi estirpe dependente e n\u00e3o promovida somente por \u00e1cidos \n\norg\u00e2nicos, uma vez que n\u00e3o foi totalmente revertida quando utilizou-se meio \n\ntamponado. O efeito da subst\u00e2ncia inibit\u00f3ria somente foi detectado em meio \n\ns\u00f3lido (m\u00e9todo \u201cspot\u201d), sugerindo a necesidade de um fator de indu\u00e7\u00e3o, \n\ncomo por exemplo, o contato com o microrganismo patog\u00eanico, para que \n\nesse seja expresso. Essa experimenta\u00e7\u00e3o corrobora a necessidade de \n\nutiliza\u00e7\u00e3o de mais de uma t\u00e9cnica na avalia\u00e7\u00e3o do efeito antagonista de \n\nbact\u00e9rias probi\u00f3ticas sobre pat\u00f3genos, uma vez que os mecanismos \n\nenvolvidos no antagonismo s\u00e3o diferentes. \n\nAs estirpes de Bifidobacterium breve de origem humana selecionadas \n\npara composi\u00e7\u00e3o do pool probi\u00f3tico (UFVCC 1083, UFVCC 1091, UFVCC \n\n1099, UFVCC 1103, UFVCC 1105, UFVCC 1108 e UFVCC 1111), utilizadas \n\nna presente experimenta\u00e7\u00e3o, n\u00e3o promoveram efeitos adversos na sa\u00fade \n\ngeral dos animais testados, uma vez que n\u00e3o induziram toxicidade oral \n\ncr\u00f4nica (n\u00e3o promovendo crescimento anormal do f\u00edgado, rins, cora\u00e7\u00e3o e \n\nba\u00e7o dos animais estudados) e nem promoveram transloca\u00e7\u00e3o de bacterias \n\ndo trato gastrointestinal para outros \u00f3rg\u00e3os ap\u00f3s 21 dias de tratamento. No \n\nentanto, recomenda-se a realiza\u00e7\u00e3o da mesma experimenta\u00e7\u00e3o com outros \n\nmam\u00edferos, incluindo humanos sadios, antes da implanta\u00e7\u00e3o dessas estirpes \n\nnos bancos de leite humano. Recomenda-se tamb\u00e9m, verificar a toxicidade \n\n\n\n 83\n\noral aguda, ministrando concentra\u00e7\u00f5es mais elevadas do pool probi\u00f3tico por \n\num menor tempo.  \n\n\n\n 84\n\n \n\nREFER\u00caNCIAS BIBLIOGR\u00c1FICAS \n\nABEE, T., ROMBOUTS, F. M., HUGENHOLTZ, J., GUIHARD, G. &amp; \n\nLETELLIER, L. Mode of action of nisin Z against Listeria monocytogenes \n\nScott A grown at high and low temperatures. Appl. Environ. Microbial., \n\n60, 1962-1968. 1994. \n\nADAWI, D., AHRN\u00c9, S., G\u00d5RAN, M. Effects of different probiotic strains of \n\nLactobacillus and Bifidobacterium on bacterial translocation and liver \n\ninjury in na acute liver injury model. International Journal of Food \n\nMicrobiology 70, 213-220, 2001. \n\nALAKOMI, H. L., SKYTTA, E., SAARELA, M., MATTILA-SANDHOLM, T., \n\nLATVA-KALA, K., HELANDER, I. M. Lactic acid permeabilizes gram-\n\nnagative bacteria by disrupting the outer membrane. Appl. Environ. \n\nMicrobial, 66, 2001-2005, 2000. \n\nAL-LAWATI, A., CROUCH,  N.D. AND ELHAG,  K. M, Antibiotic consumption \n\nand development of resistance among gram-negative bacilli in intensive \n\ncare units in Oman.  Annals of Saudi Medicine,   20(2-3):324-327. \n\n2000. \n\nAMANT, D.C., VALENTIN-BON, I.E. AND JERSE, A.E. Inhibition of Neisseria \n\ngonorrhoeae by Lactobacillus species that are commonly isolated from \n\nthe female genital tract. Infect. Immun. 70, 7169\u20137171, 2002. \n\nARAKI, T., SHINOZAKI, T., IRIE, Y., &amp; MIYAZAWA, Y., Trial of oral \n\nadministration os Bifidobacterium breve for the prevention of rotavirus \n\ninfection. Jornal of Japanese Association of Infectius Diseases 1999., 73: \n\n305-310. In: HARSHARNJIT, S.G., Probiotics to enhance anti-infective \n\ndefences in the gastrointestinal tract. Nutrition Research. VOL 17, N\u00ba5, p. \n\n755-773, 2003. \n\nARANOW, J. S., FINK, M. P. Determinants of intestinal barrier failure in \n\ncritical illness. British Journal of Anaesthesia, 77: 71-81, 1996. \n\nARNOLD, L. D.W., LARSON, E. Immunologic beneffts of breast milk in \n\nrelation to human milk banking. American Journal Infect Control 21, \n\n235-242, 1993. \n\n\n\n 85\n\nAROUTCHEVA, A., GARITI, D., SIMON, M., SHOTT, S., FARO, J., SIMOES, \n\nJ.A., GURGUIS, A. AND FARO, S. Defense factors of vaginal lactobacilli. \n\nAm. J. Obstet. Gynecol. 185, 375\u2013379, 2001. \n\nARUNACHALAM, K. D., Role of Bifidobacteria in nutrition, Medicine and \n\nTechnology. Nutrition Research Vol 19. N\u00ba 10 pp.1559-1597, 1999. \n\nASAHARA, T., NOMOTO, K., WATANUKI, M. AND YOKOKURA, T. \n\nAntimicrobial activity of intraurethrally administered probiotic \n\nLactobacillus casei in a murine model of Escherichia coli urinary tract \n\ninfection. Antimicrob. Agents Chemother. 45, 1751\u20131760, 2001. \n\nAUSTIN, D. J., KRISTINSSON, K. G., ANDERSON, R. M. The relationship \n\nbetween the volume of antimicrobial consumption in human communities \n\nand the frequency of resistance. PNAS 96, 1152\u20131156, 1999. \n\nBARBOSA, H.M, TORRES B.B, FURLANETO M.C. Microbiologia B\u00e1sica. \n\nEd. Atheneu, S\u00e3o Paulo, 1998. \n\nBAWER, A.W., KIRLY. W. M. M, SHERRIS, J. C., TURK, M., Antibiotic \n\nsusceptibility testing by standardized single disk method. American \n\nJournal of Clinical Pathology 45, 493-493, 1966. \n\nBAYER, A. S., CHOW, A. W., BETTS, D. AND GUZE, L. B. Lactobacillemia \n\nreport of nine cases, important clinical and therapeutic considerations. \n\nAmerican Journal of Medicine 64, 808- 813, 1978. \n\nBENGMARK, S. Ecological control of the gastrointestinal tract. The hole of \n\nprobiotic flora. Gut, v.42,  2-7, 1998. \n\nBERG, R. D. Bacterial Translocation From Gastrointestinal Tract. Trends in \n\nMicrobiology vol.3 n\u00ba 4, 149-154, 1995. \n\nBERG, R. D. Promotion of the translocation of enteric bacteria from the \n\ngastrointestinal tract of mice by oral treatment with penicillin, clindamycin, \n\nor metronidazole. Infect. Immun. 33, 851-861, 1981. \n\nBERG, R. D. The intestinal microflora in health and disease, Academic \n\nPress 333-352, 1983. \n\nBERG, R. D. Translocation and the indigenous gut flora. Scientif basis of \n\nprobiotic concept, 55-85, 1992. \n\nBERG, R. D., BERNASCONI, P., FOWLER, D., GAUTREAUX, M. Inhibition \n\nof C\u00e2ndida albicans translocation from the gastrointestinal tract of mice \n\n\n\n 86\n\nby oral administration of Saccharomices boulardii. Journal Infect. Dis. \n\n168, 1314-1318, 1993. \n\nBERG, R. D., GARLINGTON, A. W. Translocation of certain indigenous \n\nbacteria from the gastrointestinal tract to mesenteric lymph nodes and \n\nother organs in a gnotobiotic mouse model. Infection and Immunity 23, \n\n403-411, 1979. \n\nBERG, R. Inhibition of Escherichia coli translocation from the gastrointestinal \n\ntract by normal cecal flora in gnotobiotic or antibiotic decontaminated \n\nmice. Infect. Immun 29, 1073-1081, 1980. \n\nBERNET, M.F., BRASSART, D., NEESER, J.R. AND SERVIN, A.L. \n\nLactobacillus acidophilus LA 1 binds to cultured human intestinal cell \n\nlines and inhibits cell attachment and cell invasion by enterovirulent \n\nbacteria. Gut 35, 483\u2013489, 1994. \n\nBERNET-CAMARD, M.-F., LIEVIN, V., BRASSART, D., NEESER, J.-R., \n\nSERVIN, A.L., HUDAULT, S. The human Lactobacillus acidophilus strain \n\nLA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro \n\nand in vivo. Appl. Environ. Microbiol. 63, 2747\u20132753, 1997. \n\nBEVILACQUA, L., OVIDI, M., DI MATTIA, E., TROVATELLI, L. D., \n\nCANGANELLA, F. Screening of Bifidobacterium strains isolated from \n\nhuman faeces for antagonistic activities against potentially bacterial \n\npathogens. Microbiological Research, 158, 179-185, 2003. \n\nBEZIRTZOGLOU, E. The intestinal Microflora During the first weeks of life. \n\nAnaerobe 3, 173-177, 1997. \n\nBORBA, L. M., CASTRO, L. C.V.,.FANCESCHINE, S. C. C., FERREIRA, C. \n\nL. L. F. Composi\u00e7\u00e3o do leite humano e microbiota predominantemente \n\nb\u00edfida de lactente em aleitamento materno exclusivo. Nutrire, v. 25, n\u00ba1, \n\n135-154, 2003.  \n\nBORRIELLO, S. P., HAMMES, W. P., HOLZAPFEL, W., MARTEAU, P., \n\nSCHRENMEIR, J., VAARA, M., VALTONEN, V. Safety of Probiotics That \n\nContain Lactobacilli or Bifidobacteria. Clinical Infectious Diseases 36, \n\n775-780, 2003. \n\nBROOK, I., MACVITTIE, T.J., and WALKER, R. I., Recovery of aerobic and \n\nanaerobic bacteria from irradiated mice. Infection and Immunity; 46: \n\n270\u2013271, 1984 \n\n\n\n 87\n\nBROOKS, G. F., BUTEL, J. S. &amp; MORSE, S. A. Microbiologia M\u00e9dica, 21 \n\ned., Rio de Janeiro: Guanabara Koogan S.A., p. 117-141, 2000. \n\nBRUNO, F.A., SHAH, N.P. Inhibition of pathogenic and putrefactive \n\nmicroorganisms by Bifidobacterium sp. Milchwissenschaft, 57, 617\u2013\n\n621, 2002. \n\nBUYNAK, J. D., Understanding the longevity of the ?-lactam antibiotics and \n\nantibiotic/ ?-lactamase inhibitor combinations, Biochemical \n\nPharmacology, 8890: 11-22, 2005. \n\nBYEZKOWSKI, J., GESSNER, T., Biological role of superoxide \u00edon-radical. \n\nInternational Journal of Biochemistry, 20, 569-580, 1988. \n\nCHARTERIS, W. P., KELLY, P. M., MORELLI, L., &amp; COLLINS, J. K, \n\nSelective detection, enumeration and indentification of potentially \n\nprobiotic Lactobacillus and Bifidobacterium species in mixed bacterial \n\npopulation. International Journal of Food Microbiology 35, 1-27. \n\n1997. \n\nCHARTERIS, W. P., KELLY, P. M., MORELLI, L., COLLINS, J. K. Antibiotic \n\nsusceptibility of potentially probiotic Bifidobacterium isolates from the \n\nhuman gastrointestinal tract. Let. Appl. Microbiol., v. 26, 333-337, 1998. \n\nCHRISTIAN, S.S, CHRISTIAN, J. F., The cephalosporin antibiotic. Elsevier \n\nScience, 1068-607, 168-174,  1997. \n\nCHULADA, P.C., ARABES S.J. Jr,  DUNSON, D., ZELDIN, D.C., Breast-\n\nFeeding and the prevalence of  asthma and wheeze in children:analyses  \n\nfrom the third National Healt and Nutrition Examination Survery. Allergy \n\nclin Immunol, v. 111, p.328-336, 2003. \n\nCLEVELAND, J., MONTVILLE, T. J., NES, I. F., CHIKINDAS, M. L. \n\nBacteriocins: safe, natural antimicrobials for food preservation. \n\nInternational Journal of Food Microbiology, 71, 1-20, 2001. \n\nCOCONNIER, M.H., LIEVIN, V., BERNET-CAMARD, M.F., HUDAULT, S. \n\nAND SERVIN, A.L. Antibacterial e.ect of the adhering human \n\nLactobacillus acidophilus strain LB. Antimicrob. Agents Chemother. 41, \n\n1046\u20131052, 1997. \n\nCOLLADO, M. C., HERNANDEZ, M., SANZ, Y. Production of Bacteriocin-\n\nLike Inhibitory Compounds by Human Fecal Bifidobacterium Strains. \n\nJournal of Food Protection vol 68, n\u00ba5 pp 1034-1040, 2005a. \n\n\n\n 88\n\nCOLLADO, M.C., GONZ\u00c1LEZ, A., GONZ\u00c1LEZ, R., HERN\u00c1NDEZ, M., \n\nFERR\u00daS, M.A., SAZ, Y., Antimicrobial peptides are among the \n\nantagonistic metabolites produced by Bifidobacterium against \n\nHelicobacter pylori. International Journal of Antimicrobial Agents, 25, \n\np. 385-391, 2005b. \n\nCOLLINS, M.D. e GIBSON, G.R. Probiotcs, prebiotics and synbiotics: \n\napproaches for modulating the microbial ecology of the gut. Am J. Clin. \n\nNutr., v69 (suppl), p. 1052S-1057S, 1999. \n\nCOMMANE, D., HUGHES, R., SHORTT, C., ROWLAND, I. The potential \n\nmechanisms involved in the anti-carcinogenic action of probiotics. \n\nMutation Research 591, 276-289, 2005. \n\nCONDE, M. R. G. Transloca\u00e7\u00e3o e desaparecimento de c\u00e9lulas vi\u00e1veis de \n\nLactobacillus acidophilus em ba\u00e7o, f\u00edgado, rins e cora\u00e7\u00e3o de ratos. \n\nUniversidade Federal de Vi\u00e7osa, 2001 56p. (Tese MS) \n\nCOUTSOUDIS, A., PILLARY, K., SPOONER, E., KUHN, L., COOVADIA, \n\nH.M Influence of infant-feeding patterns on early mother-to-chil \n\ntransmission of HIV-1, 2003. In: American Academic Of Pediatrics. \n\nBreastfeeding and the use of human milk, Pediatrics, v. 115, n\u00ba2, 2005. \n\nCROCIANI, F., ALESSANDRINI, A, MUCCI, M. M . BIAVATI, B., Degradation \n\nof complex carbohydrates by Bifidobacterium spp. International Journal \n\nof Food Microbiology 24, 199-210, 1994. \n\nDANIELSEN, M; WIND, A. Susceptibility of Lactobacillus ssp. to antimicrobial \n\nagents. International Journal od Food Microbiology  82, 1-11, 2003. \n\nDEITCH, E. A. Multiple organ failure: pathophysiology and potencial future \n\ntherapy. Ann. Surg. 216, 117-134, 1992. \n\nDUFFY, L. C., ZIELEZNY, M. A., RIEPENHOFF-TALTY, M., DRYJA, D., \n\nSAYAHTAHERI-ALTAIE, S., GRIFFITHS, E., RUFFIN, D., BARRETT, \n\nH., ROSSMAN, J., OGRA, P.L. Effectiveness of Bifidobacterium bifidum \n\nin mediating the clinical course of murine rotavirus diarrhea. Pediatr. \n\nRes., 35: 690-695, 1994. \n\nDUGGAN, C., GANNON, J., WALKER, W. A., Protective nutrients and \n\nfuncional foods for the gastrointestinal trac. American Journal of \n\nclinical nutrition, 75, p. 789-808, 2002. \n\n\n\n 89\n\nEIZAGUIRRE, I., URKIA, N. G., ASENSIO, A. B., ZUBILAGA, P., VIDALES, \n\nC., ARENZANA, J. M. G., ALDAZABAL, P., Probiotic suplementation \n\nreduces the risk of bacterial translocation in experimental short bowel \n\nsyndrome. Journal of Pediatric Surgery vol 37, n\u00ba 5, p.699-702, 2002. \n\nFERREIRA, C. L. L. F. Prebioticos e Probi\u00f3ticos: Atualiza\u00e7\u00e3o e \n\nProspec\u00e7\u00e3o Ed. Suprema Gr\u00e1fica e Editora, 1\u00aa ed, Vi\u00e7osa-MG, 2003. \n\nFLEMING, H. P., ETCHELLS, J.L., COSTILOW, R.N., Microbial inhibition by \n\nna isolate of Pediococcus from cucumber briner. Applied Microbiology \n\n;30(6):1040-2, 1975. \n\nFOOKS, L. J ., GIBSON, G. R., Probiotics as modulators of the gut flora. Br. \n\nJ. Nutr. 88, 39-49, 2002. \n\nFOOKS, L. J., FULLER, R., GIBSON, G. R Prebiotics, probiotics and human \n\ngut microbiology. International Dairy Journal, 9, 53-61, 1999. \n\nFOOKS, L. J., GIBSON, G. R., Mixed culture fermentation studies on the \n\neffects of synbiotics on the human intestinal pathogens Campylobacter \n\njejuni and Escherichia coli, Anaerobe, 9: 231-242, 2003. \n\nFORESTIER, C., DE CHAMPS, C., VATOUX, C. AND JOLY, B. Probiotic \n\nactivities of Lactobacillus casei rhamnosus: in vitro adherence to \n\nintestinal cells and antimicrobial properties. Res. Microbiol. 152, 167\u2013\n\n173, 2001. \n\nFUJIWARA, S., HASHIBA, H., HIROTA, T., FORSTNER, J. F., \n\nProteinaceous factor(s) in culture supernatant fluids of bifidobacteria \n\nwhich prevents the binding of enterotoxigenic Eschericchia coli to \n\ngangliotetraosylceramide. Applied end Envirommental Microbiology, \n\n63, 506-512, 1997. \n\nFULLER, K. G., BERG, R. D., Microflora Control and its Applications to the \n\nBiomedical Sciences (Wostmann, B. S., ed), pp. 195-198, Alan R. Liss \n\n1985. In: BERG, R. D. Bacterial translocation from the gastrointestinal \n\ntract. Trends in Microbiology 149, v. 3. n\u00ba 4, 1995. \n\nFULLER, R. History and development of probiotics. In: R Fuller (Ed) \n\nProbiotics. The Science basis. New York. Chapman and hall,  p. 111-\n\n144, 1992.  \n\n\n\n 90\n\nGAGNON, M., KHEADR, E. E., LE BLAY, G., FLISS, I. In vitro inhibition of \n\nEschericchia coli O157:H7 by bifidobacterial strains of human origin. \n\nInternational Journal of Food microbiology, 92, 69-78, 2004. \n\nGARNEAU, S., MARTIN, N. I., VEDERAS, J. C. Two-peptide bacteriocins \n\nproduced by lactic acid bact\u00e9ria. Biochimie, 84, 577-592, 2002. \n\nGASSER, F. Safety of lactic-acid bacteria and their occurrence in human \n\nclinical infections. Bulletin de L\u2019Istitut Pasteur, 92: 45-67. 1994. \n\nGAUTREAUX, M. D., DEITCH, E. A, BERG, R. D  Microecol. Ther 20, 31-\n\n34, 1990. \n\nGAUTREAUX, M. D., DEITCH, E. A., BERG, R. D., Infect Immun 62, 2874-\n\n2884, 1993. \n\nGIBSON, G. R., ROBERFROID, M. B. Dietary Modulation of the Human \n\nColonic Microbiota: Introducing the Concept of Prebiotics. Journal of \n\nNutrition 125, 1401-1412 1995. \n\nGIBSON, G. R., WANG, X. Regulatory effects of Bifidobacteria on the growth \n\nother colonic bacteria. Journal of Applied Bacteriology 7, 412-420, \n\n1994. \n\nGIUGLIANI, E. R. J. Rede Nacional de Bancos de Leite Humano do Brasil: \n\nTecnologia para Exportar. Jornal de Pediatria v. 78, n\u00ba3, 2002. \n\nGOLDING J, Unnatural constituints of breast milk: medication, lifestyle, \n\npollutants, viruses. Early Human Development, v. 49: S29-S43, 1997. \n\n(Suppl.). \n\nGOMES, A. M. P., MALCATA, F. X. Bifidobacterium spp. and Lactobacillus \n\nacidophilus biological, biochemical, technological and therapeutical \n\nproperties relevant for use as probiotics. Trends in Food Science &amp; \n\nTechnology 10, 139-157, 1999. \n\nGONZ\u00c1LEZ-MART\u00cdNEZ, B. E.  TREVI\u00d1O, M. G., JIM\u00c9NEZ-SALAS, Z. \n\nBacteriocinas de probi\u00f3ticos. Revista de la Facultad de Salud P\u00fablica \n\ny Nutrici\u00f3n, Vol 4 No.2 , 2003.  \n\nGOODMAN, L. S.; GILMAN, A. As bases farmacol\u00f3gicas da terap\u00eautica. \n\n8a ed. Rio de Janeiro: Guanabara Koogan, 1991. 1232p. \n\nGRIFFIN, I. J., DAVILA, P. M., ABRAMS, S. A., Non-digestible \n\noligosaccharides and calcium absorption in girls with adequates calcium \n\nintakes, British Journal of Nutrition, 87, 187-191, 2002. \n\n\n\n 91\n\nGUARNER, C., RUNYON, B. A., YOUNG, S., HECK, M., SHEIKH, M. Y. \n\nIntestinal bacterial overgrowth and bacterial translocation in cirrhotic rats \n\nwith ascites. Journal of Hepatology, 26, 1372-1378, 1997. \n\nGUARNER, C., SORIANO, G., TOMAS, A., BULBENA, O., NOVELLA, M., \n\nBALANZO, J., VILARDELL, F., MOURELLE, M., MONCADA, S. Incresed \n\nserum nitrite and nitrate in patients with cirrhosis of the liver: relationship \n\nto endotoxemia. Hepatology, 18, 1139-1143, 1993. \n\nGUARNER, F., MALAGELADA, J. R., Gut flora in health and disease. \n\nLancet, 361, 512-519, 2003. \n\nGUYTON, A. C. Fisiologia Humana, 6. ed., Rio de Janeiro: Guanabara \n\nKoogan, 348p, 1988. \n\nGUYTON, A. C. Fisiologia Humana, 9. ed., Rio de Janeiro: Guanabara \n\nKoogan, 1013, 1997. \n\nHARSHARNJIT, S. GILL. Probiotics to enhance anti-infective defences in the \n\ngastrointestinal tract. Best Practive &amp; Research Clinical \n\nGastroenterology Vol 17, N\u00ba 5, pp 755-773, 2003 \n\nHATA, D., YOSHIDA, A, OHKUBO, H., Meningitis caused by Bifidobacterium \n\nin infant.  Pediatr. Infect. Dis. J., v. 7, 669-671, 1988. \n\nHEINIG, M. J., Host defense benefits of breastfeeding for the infant effect of \n\nbreastfeeding duration and exclusivily. Pediatr. Clin. North. Am. 48, \n\n105-123, 2001. \n\nHILTON, E., RINDOS, P., &amp; ISENBERG, H.D Lactobacillus GG vaginal \n\nsuppositories and vaginitis. Jornal of Clinical Microbiology, 33, 1433. \n\n1995. \n\nHOYOS, A. B. Reduced incidence of necrotizing enterocolitis associated with \n\nenteral administration of Lactobacillus acidophilus and Bifidobacterium \n\ninfantis to neonates in an intensive care unit. International Jornal of \n\nInfecctious Diseases, 3, 197-202. 1999. \n\nHUIS IN\u00b4TVELD, J.H.J., SHORTT, C. Selection criteria for probiotic \n\nmicrorganisms. In: LEEDS, A.R., ROWLAND, I.R. Ed . Gut Flora and \n\nHealthc \u2013 past, present and future. Internacional Congress and \n\nSymposium 219, Royal Society of Medicine Press Limited  p.27-36.1996. \n\nIBRAHIM, S., BEZKOROVAINY, A., Inhibition of Escherichia coli by \n\nbifidobacteria. Journal of Food Protection, 56, 713-715, 1993. \n\n\n\n 92\n\nISHIBASHI, N., YAMAZAKI, S. Probiotics and Safety. Journal Clin Nutr 73 \n\n(suppl):465S-70S, 2001. \n\nISOLAURI, E. Probiotics: effects on immunity. Am. J. Clin. Nutr. 73, 444-\n\n450, 2001. \n\nISOLAURI, E., ARVOLA, T., SUTAS, Y, MOILANEN, E., &amp; SALMINEN, S. \n\nProbiotics in the management of atopic eczema. Clinical and \n\nexperimental allergy, 30, 1604-1610. 2000. \n\nJUNIOR, M. A. S, FERREIRA, E. S, CONCEI\u00c7\u00c3O, G. C.,  Betalactamases \n\nde spectro ampliado (ESBL): um importante mecanismo de resist\u00eancia \n\nbacteriana e sua detec\u00e7\u00e3o no laborat\u00f3rio cl\u00ednico. NewsLab, edi\u00e7\u00e3o 63, \n\n2004. \n\nKABIR, A. M.., AIBA, Y., TAKAGI, A, KAMIYA, S., MIWA, T., KOGA, Y. \n\nPrevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic \n\nmurine model. Gut, 41, 49-55, 1997. \n\nKALLIOMAKI, M., SALMINEN, S., ARVILOMMI, H., KERO, P., KOSKINEN, \n\nP., ISOLAURI, E., Probiotics in primary prevention of atopic disease: a \n\nrandomised placebo-controlled trial. Lancet, 357. 1076-1079, 2001 \n\nKASHKET, E. R., Bioenergetics of lactic acid bact\u00e9ria: Cytoplasmic pH and \n\nosmotolerance. FEMS Microbiology Reviews, 46, 233-244, 1987. \n\nKHEADR, E., BERNOUSSI, N., LACROIX, C., FLISS, I. Comparison of the \n\nsensibility of commercial trains and infant isolates of bifidobacteria to \n\nantibiotics and bacteriocins. International Dairy Journal 14, 1041-1053, \n\n2004. \n\nKIM, K, PICKERING, K, DUPONT, H.L, SULLIVAN, N, WILKINS, T. In vitro \n\nand in vivo neutralizing activity of human colostrum and milk against \n\npurified toxins A and B of Clostridium dificile. J Infect Diseases, v. 150, \n\n57-62, 1984. \n\nKLAENHAMMER, T. R., Bacteriocins of lactic acid bact\u00e9ria. Biochemie 70, \n\n337-349, 1988. \n\nKLEIN, G., PACK, A., BONAPARTE, C. AND REUTER, G. Taxonomy and \n\nphysiology of probiotic lactic acid bacteria. International Journal of \n\nFood Microbiology 41, 103-125, 1998. \n\n\n\n 93\n\nKOPP-HOOLIHAN, L, Prophylactic and therapeutic uses of probiotics: A \n\nreview. Journal of American Dietetic Association, 101, 229-238 quiz \n\n239-241, 2001. \n\nKOROIKOVAS, A.; BURCKHALTER, J. H. Qu\u00edmica farmac\u00eautica. Rio de \n\nJaneiro: Guanabara Koogan,1988. 783p. \n\nKUNZ C, RODRIGUEZ-PALMERO M, KOLETZKO B, JENSEN R. Nutritional \n\nand biochemical properties of human milk, part I: general aspects, \n\nproteins and carbohydrates. Clin Perinatol, v. 26, 307-333, 1999. \n\nLAWRENCE, R.A, LAWRENCE, R.M. Breastfeeding: A Guide for the Medical \n\nProfession. St Louis, 1999. \n\nLAZDUNSKI, C.J. Pore-forming colicins: synthesis, extracellular release, \n\nmode of action, immunity. Biochimie 70, 1291\u20131296, 1988. \n\nLEHTO, E.M. AND SALMINEN, S.J. Inhibition of Salmonella typhimurium \n\nadhesion to Caco-2 cell cultures by Lactobacillus strain GG spent culture \n\nsupernate: only a pH effect? FEMS. Immunol. Med. Microbiol. 18, 125\u2013\n\n132, 1997. \n\nLI\u00c9VIN, V., PEIFFER, I., HUDAULT, S., ROCHT, F., BRASSART, D., \n\nNEESER, J. R., SERVIN, A.L. Bifidobacterium strains from resident \n\ninfant human gastrointestinal microflora exert antimicrobial activity. Gut, \n\n47, 646-652, 2000. \n\nLIM,  K. S.,  HUH,  C. S.  AND  BAEK, Y. J, Antimicrobial susceptibility of \n\nbifidobacteria.  J.  Dairy   Sci.  76, 2168-2174. 1993.   \n\nLIN, S. Y., CHEN, C. T., Reduction of cholesterol by Lactobacillus \n\nacidophilus in culture broth. Journal Food Drug Anal., 8, 97-102, 2000. \n\nLJUNGDAHL, M., LUNDHOLM, M., KATOULI, M., et al. Bacterial \n\ntranslocation in experimental shock is dependent on the strains in the \n\nintestinal flora. Scandinavian Journal of Gastroenterology; 35: 389\u2013\n\n397, 2000. \n\nLUCAS, A, COLE, T. J. Breast milk and neonatal necrotising enterocolitis. \n\nLancet, 336: 1519-1523, 1990. \n\nMA, L., DEITCH, E., SPECIAN, R., STEFFEN, E., BERG, R., Translocation \n\nof Lactobacillus murinus from the gastrointestinal tract. Curr. Microbiol, \n\n20, 17-184, 1990. \n\n\n\n 94\n\nMACKIE, R. I., SGHIR, A., GASKINS, H. R. Developmental microbial ecology \n\nof teh neonatal gastrointestinal tract. Am. J. Clin. Nutr., v.69, 1035S-\n\n1045S, 1999. \n\nMAEJIMA, K., DEICH, E. A and BERG, R. D. Promotion by burn stress of the \n\ntranslocation of bacteria from the gastrointestinal tracts of mice. Arch. \n\nSurg, 119, 166-172, 1984. \n\nMAKRAS, L., DE VUYST, L. The in vitro inhibition of Gram-negative \n\npathogenic bact\u00e9ria by bifidobacteria is caused by the production of \n\norganic acids. International Dairy Journal, 2005. \n\nMAN, J.C. DE; ROGOSA, M.; SHARPE, M.E,. A medium for the cultivation of \n\nLactobacilli. Journal of Applied Bacteriology, v.23, p.130-135, 1960. \n\nMASTROMARINO, P., BRIGIDI, P., MACCHIA, S., MAGGI, L., PIROVANO, \n\nF., TRINCHIERI, V., CONTE, U. AND MATTEUZZI, D. Characterization \n\nand selection of vaginal Lactobacillus strains for the preparation of \n\nvaginal tablets. J. Appl. Microbiol. 93, 884\u2013893, 2002. \n\nMATTILA-SANDHOLM, T., SALMINEN, S. Up-to-date on probiotics in \n\nEurope. Gastroenterol. Int. 11, 8\u201316. 1998 \n\nMAY, J.T., Human milk- tables of the antimicrobial factores and \n\nmicrobiological contaminants relevant to human milk banking, 1998. \n\nMEGHROUS, J., EULOGE, P., JUNELLES, A. M., BALLONGUE, J., \n\nPETITDEMANGE, H. Screening of Bifidobacterium strains for bacteriocin \n\nproduction. Biotechnol. Lett. 12, 575-580, 1990. \n\nMICHETTI, P., DORTA, G., WIESEL, P.H., BRASSART, D., VERDU, E., \n\nHERRANZ, M., FELLEY, C., PORTA, N., ROUVET, M., BLUM, A.L., \n\nCORTHESY-THEULAZ, I.. Effect of whey-based culture supernatant of \n\nLactobacillus acidophilus ( johnsonii) La1 on Helicobacter pylori infection \n\nin humans. Digestion 60, 203\u2013209, 1999. \n\nMIDOLO, P. D., LAMBERT, J. R., HULL, R., LUO F., GRAYSON, M. L. In \n\nvitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and \n\nlactic acid bacteria. J. App. Bacteriol., 79: 475-479, 1995. \n\nMILLER, L. G., FINEGOLD, S. M,. Antibacterial sensibility of Bifidobacterium \n\n(Lactobacillus bifidus). Journal of Bacteriology, 93, 125-130, 1967. \n\nMITSUOKA, T. Bifidobacteria and their role in human health. Journal of \n\nIndustrial Microbiology 6, 263-268, 1990. \n\n\n\n 95\n\nMITSUOKA, T. Intestinal flora and human health. Asia Pacific. J. Clin. Nutr. \n\nV.1, p.2-9, 1996. \n\nMITSUOKA, T. Microbes in the intestine- our lifelong partners Yakult Honsha \n\nCo., Std Tokyo, 1989, 104 p. \n\nMITSUOKA, T. Recente trends in research on intestinal flora. Bididobacteria \n\nand Microflora, v.1, p.3-24, 1982. \n\nMITSUOKA, T., Intestinal bacteria and health, Tokyo: Harcourt Brace \n\nJovarnovich Japan, 1978, 208p. \n\nMITSUOKA, T., Intestinal flora and aging. Nutr. Rev., v.50, 438-446, 1992. \n\nMODLER, H. W. Bifidogenics Factors \u2013 Sources, metabolism and \n\nApplications. International Dairy Journal 4, 383-407, 1994. \n\nMONTVILLE, T. J., WINKOWSKI, K., LUDESCHER, R. D., Models and \n\nmechanisms for bacteriocin action application. International Dairy \n\nJournal, 5, 797-814, 1995. \n\nMOREHOUSE, J., SPECIAN, R., STEWART, J., BERG, R. D. Promotion of \n\ntranslocation of indigenous bact\u00e9ria of mice from the GI trat by oral \n\nricinoleic acid, Gastroenterology 91, 673-682 (1986). \n\nMOUBARECK, C., GAVINI, F., VAUGIEN, L., BUTEL, M. J., DOUCET-\n\nPOPULAIRE, F. Antimicrobial susceptibility of bifidobacteria. Journal of \n\nAntimicrobial Chemotherapy, 55, 38-44. 2005. \n\nMURRAY, P. R., ROSENTHAL, K. S., KOBAYASHI, G. S. &amp; PFALLER, M. A. \n\nMicrobiologia M\u00e9dica, 3 ed., Rio de Janeiro: Guanabara Koogan S.A., p. \n\n135-141, 2000. \n\nNAKAZAWA, T., KANEKO, K., TAKAHASHI, H., INOUE, S. Neonatal \n\nmeningitis caused by Bifidobacterium breve. Brain &amp; Development, \n\nv.18, 160-162, 1996. \n\nNEWMANN, E., FERREIRA, C. L. L. F. Lactobacillus acidophilus as dietary \n\nadjunct \u201cin vitro\u201d susceptibility to gastric juice, bile salts, lysozime and \n\nchemotherapeutic agents. Revista de Microbiologia, v.26, p.59-65, \n\n1995. \n\nNICAS, T. I., COLE, C. T., PRESTON, D. \u00aa, NAGARAJAN, R., Activity of \n\nglicopeptides agaisnst vancomycin-resistant Gram positive bact\u00e9ria. \n\nAntimicrobial Agents and Chemotherapy 33, 1477-1481, 1989. \n\n\n\n 96\n\nOGAWA, M., SHIMIZU, K., NOMOTO, K., TAKAHASHI, M., WATANUKI, M., \n\nTANAKA, R., TANAKA, T., HAMABATA, T., YAMASAKI, S. AND \n\nTAKEDA, Y. Protective effect of Lactobacillus casei ssp Shirota on Shiga \n\ntoxin- producing Escherichia coli O157:H7 infection in infant rabbits. \n\nInfect. Immun. 69, 1101\u20131108, 2001. \n\nOZBAS, Z. Y., AYTAC, S. A. Behaviour of Yersinia enterocolitica and \n\nAeromonas hydrophila in yogurt made with probiotic bact\u00e9ria: \n\nBifidobacterium infantis and Lactobacillus acidophilus. Milchwiss, 50, \n\n626-629, 1995. \n\nPAIVA NETTO, J. V. Antibi\u00f3ticos e quimioter\u00e1picos em medicina veterin\u00e1ria. \n\nRio de Janeiro: Livraria Atheneu, 1989. 181p. \n\nPATHMAKANTHAN, S.,  MEANCE, S., &amp; EDWARD CA. Probiotics: a review \n\nof human studies to date and methodological approaches. Medical \n\nEcology in Health and desease 10-13. 2002 \n\nPERDIGON, G., FULLER, R., RAYA, R. Lactic acid bact\u00e9ria and their effect \n\non the immune system. Curr. Issues Intest. Microbiol, 2, 27-42, 2001. \n\nPEREZ, P.F., MINNAARD, J., ROUVET, M., KNABENHANS, C., \n\nBRASSART, D., DE ANTONI, G.L. AND SCHI.RIN, E.J. Inhibition of \n\nGiardia intestinalis by extracellular factors from lactobacilli: an in vitro \n\nstudy. Appl. Environ. Microbiol. 67, 5037\u20135042, 2001. \n\nPODOLAK, P. K., ZAYAS, J. F., KASTNER, C. L., FUNG, D. Y. C. Inhibition \n\nof Listeria monocytogenes and Escherichia coli O157:H7 on beef by \n\napplication of organic acids. Journal of Food Protection, 59, 370-373, \n\n1996. \n\nQUINTILIANI, R. Jr, SAHM, D. F, COURVALIN, P, Mechanism of resistence \n\nto antimicrobial agents, 1999. In: MONBARECK, C., GAVINI, F., \n\nVAUGIEN, L., BUTEL, M. J, POPULAIRE-DOUCET, F. Antimicrobial \n\nsusceptibility of bifidobacteria. Journal of Antimicrobial Chemotherapy \n\n55, 38-44. 2005.  \n\nRAMOS, M. P.P, CUNHA, L.. R., MALDONADO, I. C. S. C., CARLOS, I. Z., \n\nFERREIRA, C. L. L. F. Influ\u00eancia da ingest\u00e3o de Bifidobacterium breve \n\nna determina\u00e7\u00e3o das citocinas IL-4, e IL-6, INF?, PNF? e compostos \n\nintermedi\u00e1rios do nitrog\u00eanio (NO) e do oxig\u00eanio H2O2, 2006 no prelo. \n\n\n\n 97\n\nRENNE, M., KALLIOMAKI, M., ARVILOMMI, H. Effect of probiotic and \n\nbreastfeeding on the Bifidobacterium and Lactobacillus/Enterococcus \n\nmicrobiota and humoral immune responses. Journal of Pediatrics, \n\nv.147, 186-191, 2005. \n\nRIORDAN, K. O., FITZGERALD, G. F., Determination of genetic diversity \n\nwithin the genus Bifidobacterium and estimation of chromosomal size. \n\nFEMS Microbial. Lett., v. 156, p.259-264, 1997. \n\nROBREDO, B., SINGH, K. V., BAQUERO, R., MURRAY, B. E., TORRES, C. \n\nVancomycin-resistant enterococci isolated from animals and food. Int. J. \n\nFood Microbiol. 54, 197\u2013204, 2000. \n\nSAARELA, M., MOGENSEN, G.,FONDEN, R., MATTO, J., MATTILA-\n\nSANDHOLM, T., Probiotic bacteria: safety, functional and technological \n\nproperties. Journal of Biotechnology 84, 197-215, 2000. \n\nSAAVEDRA, J. M., BAUMAN, N. A., OUNG, I., PERMAN, J. A., YOLKEN,  \n\nR. H. Feeding of Bifidobacterium bifidum and Streptococcus \n\nthermophilus to infants in hospital for prevention of diarrhoea and \n\nshedding of rotavirus. Lancet., 344: 1046-1049, 1994. \n\nSALMINEN, S., ISOLAURI, E., SALMINEN, E., Clinical uses of probiotics for \n\nstabilizing the gut mucosal barrier: Successful strains and future \n\nchallenges. Antonie Van Leuwenhoek, 70: 347-358, 1996. \n\nSATTERWHITE, T. K., EVANS, D. G., DUPONT, H. L., et al. Role of \n\nEscherichia coli colonisation factor antigen in acute diarrhoea. Lancet; \n\n181\u2013184, 1978. \n\nSCARDOVI, V. In: Sneath PHA, Mair NS, sharpe me AND Holt JG, eds. \n\nBergey\u2019s Manual of Systematic Bacteriology, Baltimore, MD: Williams \n\nand Wilkins.,vol: 1418-1434. 1986 \n\nSCHIFFRIN, E. J., BRASSART, D., SERVIN, A. L., ROCHAT, F., DONNET-\n\nHUGHES, A . Imune modulation of bloood leukocytes in humans by lactic \n\nacid bacteria: criteria for strains selection. Am. J. Clin. Nutr. 66, 515-\n\n520, 1997. \n\nSEEHOFER, D., RAYES, N., SCHILLER, R., STOCKMANN, M., MULLER, \n\nA.. R., STOCKMANN, M., et al Probiotics partly reverse incresed \n\nbacterial translocation after simultaneous liver resection and colonic \n\nanastomosis in rats. Journal of Surgery Research 117, 262-271, 2004. \n\n\n\n 98\n\nSERVIN, A. L., Antagonistic activities of lactobacilli and bifidobacteria against \n\nmicrobial pathogens. Microbiology Reviews, 28, 405-440, 2004.  \n\nSGORBATI, B., BIAVATI, B. E PALENZONA, D. The genus Bifidobacterium. \n\nEm Wood, B. J. B. e Holzapfel, W. H. (eds), The Lactic Acid Bacteria Vol. \n\n2. The Genera of Lactic Acid Bacteria, cap\u00edtulo 8, pp. 279-306, Blackie \n\nAcademic, Londres, RU. 1995. \n\nSHORTT, C., The probiotic century: historical and current perspectives. \n\nTrends in Food Science and Technology 10, 411-417, 1999. \n\nSHU, Q., ZHOU, J. S.., RUTHERFURD, K. J., BIRTLES, M. J., PRASAD, J., \n\nGOPAL, P. K., GILL, H. S. Probiotic lactic acid bact\u00e9ria (Lactobacillus \n\nacidophilus HN017, Lactobacillus rhamnosus HN001 and Bifidobacterium \n\nlactis HN019) have no adverse affects on the health of mice. \n\nInternational Dairy Journal 9, 831-836, 1999. \n\nSILVA, C.H.P.M., Bacteriologia: um texto ilustrado, Teres\u00f3polis: Eventos, p. \n\n107-119, 1999. \n\nSILVA, T. M. O que s\u00e3o radicais livres. 2003.  Acesso em 15  Fev. 2006. \n\nDispon\u00edvel em \n\n<www.medstudents.com.br/content/resumos/trabalhos_radicais_livres>. \n\nSINGHAL, A, FAROOQI, I.S,  O\u2019RAHILLY, S., COLE, T.J, FEWTRELL, M., \n\nLUCAS, A. Early nutrition and leptin concentrations in later life. Am clin \n\nNutr, v. 75, 993-999, 2002 \n\nSLOCUM, M. M., SITTIG, K. M., SPECIAN, R. D. Absence of intestinal bile \n\npromotes bacterial translocation. American Surgeon 58, 305-310, 1992. \n\nSNIJDERS, J. M., VAN LOGTESTIJN, J. G., MOSSEL, D. A. A., \n\nSMULDERS, F. J. M. Lactic acid as a decontaminant in slaughter and \n\nprocessing procedures. Veterinary Quarterly, 7, 27-282, 1985. \n\nSOUZA, D. F. M. C.; FERREIRA, C. L. L. F. ; SOUZA, A. V. C., COSTA, N. \n\nM. B., YBARRA, L. M., AZEREDO, E. M. C. Transloca\u00e7\u00e3o de \n\nLactobacillus acudiphilus em ratos alimentados com dieta rica em \n\ncolesterol e \u00e1cido c\u00f3lico suplementada com probi\u00f3tico. Ci\u00eancia e \n\nTecnologia de Alimentos, Campinas, v. 24, n. 04, p. 522-526, 2004. \n\n \n\n\n\n 99\n\nSPAETH, G., BERG, R. D., PPECIAN, R. D., AND DEITCH, E. A, Food \n\nwithout fiber promotes bacterial translocation from the gut. Surgery, 108, \n\n240-247, 1990. \n\nSPAETH. G., GOTTWALD, T., SPECIAN, R. D., MAINOUS, M. R., BERG, R. \n\nD., DEITCH, E. A. Secretory immunoglobulin A, intestinal micin, and \n\nmucosal permeability in nutritionally-induced bacterial translocation in \n\nrats. Ann. Surg. 220, 798, 1994. \n\nSREEKUMAR, O., HOSONO, A. The antimutagenic properties of a \n\npolysaccharide produced by Bifidobacterium longum and its cultured milk \n\nagainst some heterocyclic amines. Can. J. Microbiol, 44, 1029-1036, \n\n2003. \n\nSTEFFEN, E. K., BERG, R. D., and DEITCH, E. A. J. Infect. Dis 157, 1032-\n\n1037, 1988. \n\nSTRUS, M., PAKOSZ, K., GOSCINIAK, H., PRZONDO-MORDARSKA, A., \n\nROZYNEK, E., PITUCH, H., MEISEL-MIKOLAJCZYK, F. AND HECZKO, \n\nP.B. Antagonistic activity of Lactobacillus bacteria strains against \n\nanaerobic gastrointestinal tract pathogens (Helicobacter pylori, \n\nEscherichia coli, Campylobacter jejuni, Clostridium difficile). Med. Dosw. \n\nMikrobiol. 53, 133\u2013142, 2001. \n\nSUZUKI, T., ITOH, K., KANEKO, T., SUZUKI, H. Inhibition of bacterial \n\ntranslocation from the gastrointestinal tract of mice by oral admistration of \n\na culture condensate of Bifidobacterium longum. J. Vet. Med. Science. \n\n59 (8): 665-669, 1997. \n\nSWANK, G. M., DEITCH, E. A., Role of the gut in multiple organ failure: \n\nBacterial translocation and permeability changes. World. J. Surg. 20, \n\n411-417, 1996. \n\nSZAJEWSKA, H., MRUKOWICZ, J. Z, Probiotics in the tratament and \n\nprevention of acute infectious diarrhea in infants and children. Jornal of \n\nPediatric Gastroenterology and Nutrition, 33, p 17-25 2001. \n\nTAGG, J. R., DAJANI, A. S., WANNAMAKER, L. W., Bacteriocins of Gram \n\npositive bacteria. Bacteriol. Rev. 40, 722-756, 1976. \n\nTANAKA, R.,  AND SHIMOSAKA, K.,  Investigation of the stool frequency in \n\nelderly who  are bedridden and is improvement by ingesting of bifidus \n\nyorgut. J. Geriar. 19:577-582, 1982. \n\n\n\n 100\n\nTANNOCK. G. W. Probiotics \u2013 a critical review. England: Horizon Scientific \n\nPress, 1999, p. 5-14, 1999. \n\nTAVARES, W. Manual de Antibi\u00f3ticos e Quimioter\u00e1picos \n\nAntiinfecciosos. S\u00e3o Paulo: Atheneu, 1990. \n\nTAVARES, W. Manual de antibi\u00f3ticos e quimioter\u00e1picos antiinfecciosos. \n\n3\u00aa ed. S\u00e3o Paulo: Atheneu, p. 292, 2001. \n\nTESHIMA, E. Sele\u00e7\u00e3o de Bact\u00e9rias B\u00edfidas Isoladas de Lactentes e \n\nModula\u00e7\u00e3o da Microbiota Intestinal por Meio de Probi\u00f3ticos, Prebi\u00f3ticos \n\ne Simbi\u00f3ticos, Universidade Federal de Vi\u00e7osa, 2001 113p. (Tese DO). \n\nTESHIMA, E., BORBA, L., RAMOS, M. P. P., CUNHA, L. R., FERREIRA, C. \n\nL. L. F. Bact\u00e9rias B\u00edfidas End\u00f3genas Probi\u00f3ticas para Uso em Bancos de \n\nLeite Humano. I Congresso Mineiro de Alimenta\u00e7\u00e3o e Nutri\u00e7\u00e3o \u2013 A \n\nCi\u00eancia por um Brasil sem Fome. 2005. \n\nTICHACZEK, P. S., NISSEN-MEYER, J., NES, I. F., VOGEL, R. F., \n\nHAMMES, W. P. Characterization of the bacteriocins curvacin A from \n\nLactobacillus curvatum LTH1174 and sakacin P from Lactobacillus sake \n\nLTH673. Sys. Appl. Microbiol 15, 460-468, 1992. \n\nTISSIER, H,. Le Bacterium coli et le r\u00e9action chromophilr d\u2019 Escherich. C. R. \n\nSoc. Biol. 51:943, 1899. \n\nTORTORA G. J, FUNKE B. R, CASE C. L. Microbiologia. Ed. Artes M\u00e9dicas \n\nSul, 6\u00aaed, Porto Alegre, 2000. \n\nTOSIN I. Avalia\u00e7\u00e3o do modo de dissemina\u00e7\u00e3o da resist\u00eancia bacteriana a \n\nantibacterianos nos hospitais brasileiros. S\u00e3o Paulo; s. n; [137] p. 2001. \n\nTOUR\u00c9, R., KHEADR, E., LACROIX, C., MORONI,  O.,FLISS, I Production \n\nof antibacterial substances by bifidobacterial isolates from infant stool \n\nactive against Listeria monocytogenes. Journal od Apllied \n\nMicrobiology, 95, 1058-1069, 2003. \n\nTOZZI, A.E, PEZZOTTI, P., GRECO, D., Does breastfeeding delay \n\nprogression to AIDS in HIV-infected children? AIDS, v.4:1, 293-400, \n\n1990. \n\nVASSEUR, C., BAVAREL, L., HEBRAUD, M., LABADIE, J., Effect of osmotic \n\nalkaline, acid or thermal stresses on the growth and inihibition of Listeria \n\nmonocytogenes. Journal of Applied Microbiology, 86, 469-476, 1999. \n\n\n\n 101\n\nVELRAEDS, M. C., VAN DER MEI, H. C., REID, G., BUSSCHER, H. J. \n\nInhibition of initial adhesion of uropathogenic Enterococcus faecalis by \n\nbiosurfactants from Lactobacillus isolates. Appl. Environ. Microbiol. 62, \n\n1958\u20131963, 1996. \n\nVIEIRA, G. O., SILVA, L. R., VIEIRA, T. O. Alimenta\u00e7\u00e3o infantil e morbidade \n\npor diarr\u00e9ia. J. Pediatr, 79(5), 449-454, 2003. \n\nWALSH, C. Molecular mechanisms that confer antibacterial drug resistence. \n\nNature; 406: 775-81, 2000. \n\nWELLS CL. Relationship between intestinal microecology and the \n\ntranslocation of intestinal bacteria. Antonie van Leeuwenhoek, 58: 87\u2013\n\n93, 1990. \n\nWELLS, C. L., JECHOREK, R. P., ERLANDSEN, S. L.  Inhibitory effects of \n\nbile on bacterial invasion of enterocytes: possible machanism for \n\nincreased translocation associated with obstructive jaundice. Critical \n\nCare Medicine 23, 301-307, 1995. \n\nWELLS, C. L., MADDUS, M. A.,SIMMONS, R. L. Role of the macrophage in \n\nthe translocation of intestinal bacteria. Archives of Surgery 122, 48-53, \n\n1987. \n\nWIEST, R., RATH, H. C. Bacterial Translocation in the Gut. Best Practice &amp; \n\nResearch Clinical Gastroenterology vol 17, n\u00ba 73, 397-425, 2003. \n\nWILLIANS, R., STEHLIN, I., Breast milk or formula: making the right choice \n\nfor your baby, Adapted from FDA consumer, 2005. \n\nWILMORE, D. W., SMITH, R. J., O\u2019DWYER, S. T., JACOBS, D. O., \n\nZIEGLER, T. R., WANG, X. The gut: a central organ after stress. \n\nSurgery 104, 917-923, 1988.  \n\nWORK GROUP ON BREASTFEEDING AMERICAN ACADEMY OF \n\nPEDIATRICS. Breastfeeding and the use of human milk. Pediatrics, v. \n\n100, 1035-1039, 1997. \n\nWRIGHT, A. V, Regulating the Safety of Probiotics. The European Approach. \n\nCurrent Pharmaceutical Design, 11, 17-23. 2005. \n\nYASID, A. M, ALI, A. M, SHUHAIMI, M., KALAIVAANI, V., ROKIAH, M. Y., \n\nREEZAL, A. Antimicrobial susceptibility of bifidobacteria. Letters in \n\nApplied Microbiology 31, 57-62, 2000. \n\n\n\n 102\n\nYASUI, H., Shida, K., Matsuzaki, T. and Yokokura, T. Immunomodulatory \n\nfunction of lactic acid bacteria. Antonie Van Leeuwenhoek 76, 383\u2013\n\n389, 1999. \n\nYILDIRIM, Z., JOHNSON, M. G., Characterization and antimicrobial \n\nspectrum of bifidocin B, a bacteriocin produced by Bifidobacterium \n\nbifidum NCFB 1454. Journal Food Protection, 61, 47-51, 1998. \n\n YILDIRIM, Z., WINTERS, D. K., JOHNSON, M. G. Purification amino acid \n\nsequence and mode of action od bifidocin B produced by Bifidobacterium \n\nbifidum NCFB 1454. Journal of Applied Microbiology, 86, 45-54, 1999. \n\nYIM H\u00c1, G., YANG, C. H., KIM, H., CHONG, Y. Case of sepsis caused by \n\nBifidobacterium longum. J. Clin. Microbiol., v. 37, 1227-1228, 1999. \n\nYOLKEN, R.H, PETERSON, J.A VONDERFECHT, S.L., FOUTS, E. T, \n\nMIDDTHUN, NEWBURG, D.S. Human milk mucin inhibits rotavirus \n\nreplication and prevents experimental gastroenteritis. J. Clin. Invest, v. \n\n90, p.1984-1991, 1992. \n\nYOUNG, R. J., HUFFMAN, S., Probiotic Use in Children . Journal Pediatr \n\nHealth Care. 17 p 277-283, 2003. \n\nZHOU, J. S, PILLIDGE, C. J, GOPAL, P. K, GILL, H. S.  Antibiotic \n\nsusceptibility profiles of new probiotic Lactobacillus and Bifidobacterium \n\nstrains. International Journal of Food Microbiology  98, 211-217. 2005. \n\nZHOU, J. S., SHU, Q., RUTHERFURD, K. J., PRASAD, J., GOPAL, P. K., \n\nGILL, H. S. Acute oral toxicity and bacterial translocation studies on \n\npotencially probiotic strains of Lactic acid bact\u00e9ria.  Food and Chemical \n\nToxicology 38, 153-161, 2000a. \n\nZHOU, J. S., SHU, Q., RUTHERFURD, K. J., PRASAD, J., GOPAL, P. K., \n\nGILL, H. S. Safety assessment of potencial probiotic lactic lactic acid \n\nbacterial strains Lactobacillus rhamnosus HN001, Lb.  acidophilus \n\nHN017, and Bifidobacterium lactis HN019 in BALB/c mice. International \n\nJournal of Food Microbiology 56, 87-96, 2000b."}]}}}